Notable companies
The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN), Amgen (NASDAQ:AMGN), Regeneron Pharmaceuticals (NASDAQ:REGN), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB), Intra-Cellular Therapies (NASDAQ:ITCI).
Industry description
The investment seeks capital appreciation.
Under normal market conditions, the fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The fund predominantly invests in equity securities. In addition to its investments in biotechnology companies, the fund may also invest up to 20% of its net assets in equity or debt securities of any type of issuer. It is non-diversified.
Market Cap
The average market capitalization across the Franklin Biotechnology Discovery C MF is 83.89B. The market cap for tickers in the group ranges from 6.7B to 208.98B. AZN holds the highest valuation in this group at 208.98B. The lowest valued company is ITCI at 6.7B.
Volume
The average weekly volume growth across all stocks in the Franklin Biotechnology Discovery C MF was 9%. For the same stocks of the MF, the average monthly volume growth was 49% and the average quarterly volume growth was -7%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 57
P/E Growth Rating: 49
Price Growth Rating: 44
SMR Rating: 70
Profit Risk Rating: 36
Seasonality Score: -20 (-100 ... +100)